StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Did anyone post

<< Previous

Bullboard Posts

Next >>

Comment by JHendrixon Apr 04, 2021 1:22pm

125 Views

Post# 32935152

RE:RE:RE:RE:RE:RE:Did anyone post

Would have been better for SP if Atkinson contained emotions, but Tripp has been disappointing.

The out burst may have been purposeful as first tactic to raise investor frustration and create a movement to oust Tripp. It's not uncommon. It was definitely a shot across the bow of Tripp's ship.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project